BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8136893)

  • 1. Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia.
    Van Gool D; David G; Lammens M; Baro F; Dom R
    Dementia; 1993; 4(6):308-14. PubMed ID: 8136893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
    Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.
    Buée L; Hof PR; Bouras C; Delacourte A; Perl DP; Morrison JH; Fillit HM
    Acta Neuropathol; 1994; 87(5):469-80. PubMed ID: 8059599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease.
    Van Gool D; De Strooper B; Van Leuven F; Triau E; Dom R
    Neurobiol Aging; 1993; 14(3):233-7. PubMed ID: 7686641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid precursor protein accumulation in Lewy body dementia and Alzheimer's disease.
    Van Gool D; De Strooper B; Van Leuven F; Dom R
    Dementia; 1995; 6(2):63-8. PubMed ID: 7606281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.
    Su JH; Cummings BJ; Cotman CW
    Neuroscience; 1992 Dec; 51(4):801-13. PubMed ID: 1488123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.
    Verbeek MM; Otte-Höller I; van den Born J; van den Heuvel LP; David G; Wesseling P; de Waal RM
    Am J Pathol; 1999 Dec; 155(6):2115-25. PubMed ID: 10595940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.
    O'Callaghan P; Sandwall E; Li JP; Yu H; Ravid R; Guan ZZ; van Kuppevelt TH; Nilsson LN; Ingelsson M; Hyman BT; Kalimo H; Lindahl U; Lannfelt L; Zhang X
    Brain Pathol; 2008 Oct; 18(4):548-61. PubMed ID: 18422760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
    Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
    Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.
    Snow AD; Nochlin D; Sekiguichi R; Carlson SS
    Exp Neurol; 1996 Apr; 138(2):305-17. PubMed ID: 8620929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study.
    Lashley T; Holton JL; Verbeek MM; Rostagno A; Bojsen-Møller M; David G; van Horssen J; Braendgaard H; Plant G; Frangione B; Ghiso J; Revesz T
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):492-504. PubMed ID: 16972883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
    Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
    Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.
    Schmidt ML; Robinson KA; Lee VM; Trojanowski JQ
    Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfation of heparan sulfate associated with amyloid-beta plaques in patients with Alzheimer's disease.
    Bruinsma IB; te Riet L; Gevers T; ten Dam GB; van Kuppevelt TH; David G; Küsters B; de Waal RM; Verbeek MM
    Acta Neuropathol; 2010 Feb; 119(2):211-20. PubMed ID: 19636575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains.
    van Horssen J; Wilhelmus MM; Heljasvaara R; Pihlajaniemi T; Wesseling P; de Waal RM; Verbeek MM
    Brain Pathol; 2002 Oct; 12(4):456-62. PubMed ID: 12408231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease.
    Perry G; Siedlak SL; Richey P; Kawai M; Cras P; Kalaria RN; Galloway PG; Scardina JM; Cordell B; Greenberg BD
    J Neurosci; 1991 Nov; 11(11):3679-83. PubMed ID: 1941102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "nonamyloidogenic" p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid.
    Lalowski M; Golabek A; Lemere CA; Selkoe DJ; Wisniewski HM; Beavis RC; Frangione B; Wisniewski T
    J Biol Chem; 1996 Dec; 271(52):33623-31. PubMed ID: 8969231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and patients.
    Hosono-Fukao T; Ohtake-Niimi S; Hoshino H; Britschgi M; Akatsu H; Hossain MM; Nishitsuji K; van Kuppevelt TH; Kimata K; Michikawa M; Wyss-Coray T; Uchimura K
    Am J Pathol; 2012 May; 180(5):2056-67. PubMed ID: 22429964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid beta protein (A beta) deposition in dementia with Lewy bodies: predominance of A beta 42(43) and paucity of A beta 40 compared with sporadic Alzheimer's disease.
    Mann DM; Brown SM; Owen F; Baba M; Iwatsubo T
    Neuropathol Appl Neurobiol; 1998 Jun; 24(3):187-94. PubMed ID: 9717183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.